Back to search

United Kingdom· GB-APID-45778611000001102

Terlipressin 1mg/8.5ml solution for injection vials

A terlipressin product containing terlipressin, registered in United Kingdom by AFT Pharma UK Ltd. The same ATC class is registered in 15 of our 19 countries.

ATC H01BA04

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedTerlipressin 1mg/8.5ml solution for i…ATCH01BA04REGISTER NO.GB-APID-4577861100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Terlipressin is registered in 15 of 19 countries.

Countries holding a registration under ATC H01BA04 (terlipressin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 9 of them publish a price we can compare per daily dose

Terlipressin · ATC H01BA04

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Terlipressin
Manufacturer
AFT Pharma UK Ltd
Country
United Kingdom (GB)
ATC code
H01BA04
ATC class
Terlipressin
Defined daily dose
12 mg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5061010160134

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Terlipressin in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terlipressin products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Glycylpressin, Terlipressinacetat Ever Pharma
  • Bulgaria · Терлипресин Ацетат Ever Pharma
  • Czechia · Remestyp, Terlipresin Acetát Ever Pharma
  • Germany · Glycylpressin, Terlipressinacetat Ever Pharma
  • Spain · Terlipresina Acetato Ever Pharma
  • France · Acetate De Terlipressine Ever Pharma
  • Hungary · Glypressin
  • Ireland · Terlipressin Acetate Ever Pharma
  • Italy · Glipressina, Terlipressina Acetato Ever Pharma
  • Poland · Terlipressini Acetas Ever Pharma
  • Portugal · Glypressine, Terlipressina Ever Pharma
  • Romania · Acetat De Terlipresină Ever Pharma
  • Slovakia · Remestyp, Terlipresín Ever Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e26acc3f-9608-4675-b2f4-42e17c62dae7
GET /v1/drugs/e26acc3f-9608-4675-b2f4-42e17c62dae7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "45778611000001102",
  "desc": "Terlipressin 1mg/8.5ml solution for injection vials (AFT Pharma UK Ltd)",
  "form": "Solution for injection",
  "vpid": "45792511000001107",
  "source": "dmd",
  "vtm_id": "777717004",
  "strength": "120 microgram",
  "substance": "Terlipressin",
  "ingredient": "Terlipressin acetate",
  "supplier_code": "41968911000001107"
}

See everything about terlipressin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.